Bifodan Launches Two New Products at Vitafoods 2016

635984823787602619OralExtra_ikon.jpg

11 May 2016 --- Bifodan A/S has announced the market introduction of 2 proprietary probiotic solutions backed by clinical research: Oral Extra and FemiOral Balance.  

Susanne Andersen Bækgaard, Vice President of Marketing, told NutritionInsight: “Oral Extra is available for immediate sale in Europe and North America as a nutritional supplement. FemiOral Balance will be marketable as Medical Device within a few months, and is pending regulatory clearance before it is released in the US."

 

Oral Extra is a unique combination of two proprietary lactobacilli strains, which have been studied in a clinical trial performed by Assistant Professor Mette Kirstine Keller at the University of Copenhagen. Further analysis of microbiological effects and immunological markers is due shortly, and the study has therefore not been published yet. It is expected to be published in a peer reviewed journal.

 

The study was aimed at determining effect on oral health parameters specific to gingivitis, a condition affecting 50-90% of the adult population worldwide. The results were significantly in favor of Oral Extra, which is offered as a lozenge with a cool lemon flavor.

 

FemiOral Balance is also based on a patented combination of two proprietary strains. The effect of this unique combination on vaginal health has been studied extensively, and the level of evidence allows for a medical device certification of an orally administered capsule: “Gingival crevicular fluid is an important marker for inflammation of the gums, and the effect of the administration of Oral Extra is promising,” explained principal investigator and Assistant Professor Mette Kirstine Keller.
 “In a double-blinded, placebo controlled study recently completed, the reduction in gingival crevicular fluid was significant in the group treated with Oral Extra, compared to the placebo group.”

 

Bifodan A/S is a distinct partner in probiotic finished solutions for the private label industry. The company develops and manufactures probiotic turnkey solutions for private label customers worldwide. Based just North of Copenhagen, Denmark, Bifodan delivers clinically documented, high quality probiotic products, manufactured at their GMP approved production facility.

 

Bifodan has a long history in probiotic bacteria, as the company was founded by the first Danish dairy to isolate the lactobacillus acidophilus bacteria in 1938. Bifodan has been dedicated to research and development of probiotic nutritional supplements since 1992.

 

The products will be presented at Vitafoods Europe 2016 (10-12May 2016). “Our new product introductions are a result of Bifodan’s commitment to provide scientific documentation of the probiotic solutions we provide” says Bifodan CEO Mr. Steen Andersen. “Investing in clinical development of proprietary strains is at the core of our strategy moving forward and we are excited to present Oral Extra and FemiOral Balance at Vitafoods this year.”

 

by Kerina Tull

RELATED ARTICLES
Homepicture

Seventure Partners’ microbiome portfolio nears critical milestones 

18 Dec 2017 Seventure Partners, one of Europe’s ...

Homepicture

Soylent returns to Silicon Valley roots with retail expansion

15 Dec 2017 Rosa Foods, the makers of Soylent, has announced ...

Homepicture

Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 One of the major issues to be discussed at ...

Homepicture

Frutarom finalizes AB-Fortis micro-encapsulation technology acquisition

13 Dec 2017 Frutarom has acquired AB-Fortis activities, ...

Homepicture

Kappa Bioscience moves to expand vitamin K2 presence in US with new appointments

13 Dec 2017 Kappa Bioscience AS, maker of K2Vital vitamin K2 ...